Herbas VPB

Spausdinti
EN | LT
LT - SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS
EN - SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. C07D 403/04 (2006.01)
C07D 403/12 (2013.01)
C07D 403/14 (2006.01)
C07D 401/14 (2013.01)
A61P 1/02 (2006.01)
C07D 401/04 (2013.01)
C07D 231/14 (2006.01)
C07D 401/12 (2013.01)
A61P 1/04 (2006.01)
C07D 403/04 (2013.01)
A61P 3/10 (2006.01)
C07D 405/12 (2013.01)
C07D 413/04 (2013.01)
A61P 7/00 (2006.01)
A61P 9/00 (2006.01)
C07D 413/12 (2013.01)
C07D 417/12 (2013.01)
A61P 11/04 (2006.01)
C07D 231/14 (2013.01)
A61P 13/02 (2006.01)
A61P 1/02 (2018.01)
C07D 401/04 (2006.01)
A61P 1/04 (2018.01)
C07D 401/12 (2006.01)
A61P 11/04 (2018.01)
C07D 401/14 (2006.01)
A61P 13/02 (2018.01)
C07D 403/12 (2006.01)
A61P 13/12 (2018.01)
C07D 405/12 (2006.01)
C07D 413/12 (2006.01)
A61P 19/02 (2018.01)
A61P 25/00 (2018.01)
C07D 417/12 (2006.01)
A61P 27/02 (2018.01)
A61P 29/00 (2018.01)
A61P 31/04 (2018.01)
A61P 43/00 (2018.01)
A61P 7/00 (2018.01)
A61P 7/02 (2018.01)
A61P 7/04 (2018.01)
A61P 7/10 (2018.01)
A61P 9/00 (2018.01)
A61P 9/10 (2018.01)
A61P 9/12 (2018.01)
A61P 3/10 (2018.01)
C07D 403/14 (2013.01)
Europos patentas
(11) Patento numeris 4180424
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 22191079.7
Europos patento paraiškos padavimo data 2015-03-09
(97) Europos patento paraiškos paskelbimo data 2023-05-17
(45) Paskelbimo apie Europos patento išdavimą data 2025-06-25
(46) Apibrėžties vertimo paskelbimo data
Prioriteto paraiškos
(30) Numeris Data Šalis
201461949808 P 2014-03-07 US
201461981515 P 2014-04-18 US
Išradėjai
(72)
KOTIAN, Pravin L. , US
BABU, Yarlagadda S. , US
WU, Minwan , US
KUMAR, Satish V , US
ZHANG, Weihe , US
CHINTAREDDY, Venkat R , US
Savininkas
(73) BioCryst Pharmaceuticals, Inc. , 4505 Emperor Blvd., Durham, NC 27703, US
Pavadinimas
(54) SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS
  SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS